# PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles

> **NCT03774849** · NA · COMPLETED · sponsor: **Candela Corporation** · enrollment: 115 (actual)

## Conditions studied

- Benign Pigmented Lesions
- Facial Wrinkles

## Interventions

- **DEVICE:** PicoWay™ 532nm fractional handpiece
- **DEVICE:** PicoWay™ 730nm wavelength
- **DEVICE:** PicoWay™ 1064nm fractional handpiece

## Key facts

- **NCT ID:** NCT03774849
- **Lead sponsor:** Candela Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-05
- **Primary completion:** 2020-11-12
- **Final completion:** 2020-11-12
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774849, "PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03774849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*